Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Other Working Capital Changes (2016 - 2025)

Lipocine's Other Working Capital Changes history spans 13 years, with the latest figure at $321168.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 10.07% year-over-year to $321168.0; the TTM value through Sep 2025 reached $620482.0, up 472.74%, while the annual FY2024 figure was $1495.0, 100.45% up from the prior year.
  • Other Working Capital Changes reached $321168.0 in Q3 2025 per LPCN's latest filing, up from -$66166.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q3 2021 to a low of -$774379.0 in Q2 2022.
  • Average Other Working Capital Changes over 5 years is $20360.9, with a median of -$96803.0 recorded in 2023.
  • Peak YoY movement for Other Working Capital Changes: plummeted 891.28% in 2022, then soared 2682.16% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$29176.0 in 2021, then tumbled by 891.28% to -$289217.0 in 2022, then surged by 106.27% to $18137.0 in 2023, then skyrocketed by 2682.16% to $504600.0 in 2024, then crashed by 36.35% to $321168.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Other Working Capital Changes are $321168.0 (Q3 2025), -$66166.0 (Q2 2025), and -$139120.0 (Q1 2025).